Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Clinical trials
Year: 2018, Jahrgang: 16, Heft: 1, Pages: 20-31 |
| ISSN: | 1740-7753 |
| DOI: | 10.1177/1740774518807160 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1177/1740774518807160 Verlag, Volltext: https://jhu.pure.elsevier.com/en/publications/developing-a-risk-based-composite-neurologic-outcome-for-a-trial- 
|
| Verfasserangaben: | James F. Casella, Robert J. Adams, Donald J. Brambilla, John Strouse, Pia Maier, Rachel Dlugash, Radhika Avadhani, Krista Vermillion, James A. Tonascia, Jenifer H. Voeks, Daniel F. Hanley, Richard Thompson, and Harold P. Lehmann; for the HU Prevent Investigators |
| Beschreibung: | First published November 14, 2018 Gesehen am 29.03.2019 |
|---|---|
| Beschreibung: | Online Resource |
| ISSN: | 1740-7753 |
| DOI: | 10.1177/1740774518807160 |